Arch Biopartners Inc.
ACHFF
$1.19
-$0.005-0.42%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.72% | -46.27% | 63.26% | -25.22% | 24.12% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 643.64% | 109.95% | -174.79% | 3,020.13% | -96.85% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 120.53% | 37.93% | -87.26% | 45.45% | -66.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -95.35% | 1,311.11% | -88.54% | 528.00% |
| Total Debt Repaid | -- | -- | -- | -19.77% | -2,400.00% |
| Issuance of Common Stock | -41.53% | 13.27% | 4.54% | -43.93% | 342.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.44% | -45.88% | 116.98% | -52.28% | 312.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 464.74% | -184.10% | 223.67% | -209.89% | 112.43% |